French Renewable Energy Stock News

ENXTPA:PUB
ENXTPA:PUBMedia

Is Publicis Groupe's (ENXTPA:PUB) Targeted Buyback Quietly Redefining Its Capital Allocation Playbook?

In early February 2026, Publicis Groupe S.A. announced a fully cash 2025 proposed dividend of €3.75 per share, reported 2025 sales of €17,399 million and net income of €1,653 million, and put in place a share buyback program of up to €175 million to serve employee share plans without issuing new shares. Together with launching its new Influential Sports creator unit, these capital allocation moves highlight how Publicis is balancing investment in growth initiatives with direct returns to...
ENXTPA:TKO
ENXTPA:TKOCapital Markets

Is It Time To Revisit Tikehau Capital (ENXTPA:TKO) After Recent Three‑Year Share Price Slump

Investors may be wondering whether Tikehau Capital at €16.04 is starting to look attractively priced, or if the market still sees more risk than reward. The share price performance has been mixed recently, with a 1.3% gain over the last 7 days, a 2.8% decline over 30 days and a 1.5% return year to date, compared with a 21.4% decline over 1 year and a 31.5% fall over 3 years. Recent coverage around Tikehau Capital has focused on its role as an alternative asset manager and how sentiment...
ENXTPA:DG
ENXTPA:DGConstruction

Vinci (ENXTPA:DG) Valuation Check After 2025 Earnings Beat Dividend Lift And 2026 Growth Guidance

What Vinci’s latest earnings and dividend move mean for investors Vinci (ENXTPA:DG) just released its full year 2025 results, reporting higher revenue, net income and earnings per share, alongside a proposed dividend increase and guidance that points to further growth in 2026. For 2025, Vinci reported revenue of €75,372 million compared with €72,459 million a year earlier. Net income was €4,903 million versus €4,863 million, with basic earnings per share from continuing operations at €8.76...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Sanofi (ENXTPA:SAN) Valuation Check As CEO Transition Follows Pipeline And Vaccine Unit Challenges

Why the CEO change matters for Sanofi shareholders Sanofi (ENXTPA:SAN) is in the spotlight after the board decided not to renew Paul Hudson’s director mandate, setting his final day as CEO for February 17 and naming Belén Garijo as his successor from April 29. This leadership shift comes after reports of clinical setbacks, pressure in the US vaccine unit, limited expected pipeline catalysts for 2026, and a cautious reaction from investors, including at least one broker downgrade to...
ENXTPA:SGO
ENXTPA:SGOBuilding

Saint Gobain Expansion And Delisting Put Valuation And Access In Focus

Compagnie de Saint-Gobain has completed a major expansion at its CertainTeed Roofing facility in Georgia, supporting its manufacturing footprint in the U.S. southeast. The company has also delisted from the London Stock Exchange, concentrating trading in its primary market listings. These moves affect both Saint-Gobain's operational setup in North America and how investors access ENXTPA:SGO shares. Compagnie de Saint-Gobain, traded as ENXTPA:SGO, is currently priced at €90.86, with a 3 year...
ENXTPA:BN
ENXTPA:BNFood

Is Danone (ENXTPA:BN) Attractive After Recent Share Price Volatility?

If you are wondering whether Danone is offering fair value at its current share price, you are not alone. This article is built to help you weigh what the market is pricing in against what the fundamentals suggest. Over the past week the share price has moved 4.6%, set against a 5.2% decline over the last 30 days, a 4.9% decline year to date, and gains of 10.8% over 1 year, 53.1% over 3 years and 50.4% over 5 years. This gives useful context for any valuation work you do next. Recent news...
ENXTPA:RBT
ENXTPA:RBTChemicals

Robertet (ENXTPA:RBT) Valuation Check After 2025 Revenue Reaches €843.9m With 7.6% Organic Growth

Why Robertet’s latest revenue announcement matters for shareholders Robertet (ENXTPA:RBT) has come into focus after its board approved 2025 revenues of €843.9 million, representing a 4.5% rise, with organic growth of 7.6% supported by most divisions and regions. See our latest analysis for Robertet. The revenue update arrives as the shares show mixed momentum, with a 1-day share price return of 2.52% and a 7-day share price return of 2.03% partly offsetting a 30-day share price return decline...
ENXTPA:IPN
ENXTPA:IPNPharmaceuticals

Ipsen (ENXTPA:IPN) Valuation Check As Strong 2025 Results And Upbeat 2026 Outlook Lift Investor Optimism

Ipsen (ENXTPA:IPN) is back in focus after reporting 2025 results alongside fresh 2026 guidance, combining double digit sales and profit growth with expectations for further expansion across its portfolio and pipeline. See our latest analysis for Ipsen. The recent 4.81% 1 day share price return, together with a 33.25% year to date share price return and 40.87% 1 year total shareholder return, points to momentum building as investors react to Ipsen's 2025 results, 2026 guidance and recent...
ENXTPA:UBI
ENXTPA:UBIEntertainment

Ubisoft Q3 Franchises And Anno 117 Support Reorganization Story

Ubisoft Entertainment (ENXTPA:UBI) reported a successful third quarter, with performance supported by its major gaming franchises. The launch of Anno 117 contributed to quarterly results and added to the company's lineup of established titles. Ubisoft announced a structural overhaul, creating specialized Creative Houses to focus on different parts of its game portfolio. The company is also implementing a voluntary headcount reduction as part of its broader reorganization plan. Ubisoft,...
ENXTPA:RNO
ENXTPA:RNOAuto

A Look At Renault (ENXTPA:RNO) Valuation As Earnings Anticipation Lifts Sentiment

Renault (ENXTPA:RNO) moved higher after hours as traders looked ahead to the 18 February 2026 earnings release, with attention firmly on margin recovery, electric vehicle profitability and cash generation. See our latest analysis for Renault. At a share price of €32.8, Renault’s recent 1 day share price return of 1.90% and 7 day share price return of 6.25% sit against a 1 year total shareholder return decline of 34.49%. This suggests that short term momentum has picked up while longer term...
ENXTPA:ETL
ENXTPA:ETLMedia

Assessing Eutelsat Communications (ENXTPA:ETL) Valuation After Mixed Returns And Long Term Growth Plans

What stands out in Eutelsat Communications today Eutelsat Communications (ENXTPA:ETL) has caught investor attention after recent price moves, with the share last closing at €2.24 and showing mixed returns between the past month, past 3 months, and over the past year. See our latest analysis for Eutelsat Communications. The recent 5.16% 1 day share price return and 6.41% 7 day share price return at €2.24 comes after a weak 90 day share price return of a 30.43% decline. The 1 year total...
ENXTPA:CS
ENXTPA:CSInsurance

Is AXA (ENXTPA:CS) Using Satellite Data To Quietly Redefine Its Risk Edge?

Planet Labs recently announced a partnership with AXA’s Digital Commercial Platform to supply high-frequency satellite imagery that AXA will feed into its AI-driven system to monitor, predict, and respond to natural and human-caused disasters in near-real time. This collaboration highlights how AXA is trying to enhance climate and catastrophe risk assessment by combining continuous Earth observation data with its existing risk management capabilities. Next, we’ll explore how integrating...
ENXTPA:AIR
ENXTPA:AIRAerospace & Defense

Should Air Canada’s A350-1000 Order Shape Airbus (ENXTPA:AIR) Investors’ View on Long-Haul Backlog Quality?

In early February 2026, Air Canada disclosed a firm order for eight Airbus A350-1000 widebody aircraft, with rights to purchase eight more, to modernize its long-haul fleet and support future ultra-long-haul routes from Canada to markets such as India, Southeast Asia, and Australia. This win further entrenches the A350 family as a core platform for global network carriers, reinforcing Airbus’s position in fuel-efficient, long-range widebodies at a time when airlines are prioritizing lower...
ENXTPA:RMS
ENXTPA:RMSLuxury

Hermès (ENXTPA:RMS) Margin Compression Challenges Premium Valuation Narrative

Hermès FY 2025 earnings: margins stay rich as growth expectations stay in focus Hermès International Société en commandite par actions (ENXTPA:RMS) has wrapped up FY 2025 with second half revenue of about €8.0b, basic EPS of €21.73 and net income of €2.3b, setting the tone for how investors read its latest luxury spending update. The company has seen revenue move from €7.7b and EPS of €21.32 in the second half of 2024 to around €8.0b and EPS of €21.73 in the second half of 2025. Trailing...
ENXTPA:OR
ENXTPA:ORPersonal Products

L'Oréal (ENXTPA:OR) Margin Slip To 13.9% Tests Premium Valuation Narrative

L'Oréal (ENXTPA:OR) has put fresh numbers on the table for FY 2025, with second half revenue of €21.6b, basic EPS of €5.17 and net income of €2.8b, alongside trailing 12 month revenue of €44.1b, EPS of €11.48 and net income of €6.1b. The group has seen revenue move from €21.4b in the second half of 2024 to €21.6b in the latest half, while basic EPS shifted from €5.15 to €5.17 over the same periods. This sets up a story where investors are weighing solid top line scale against a slightly...
ENXTPA:ATO
ENXTPA:ATOIT

Assessing Atos (ENXTPA:ATO) Valuation After Recent Share Price Weakness And Restructuring Progress

Atos (ENXTPA:ATO) has been drawing attention after recent price moves, with the shares closing at €44.50. Investors are weighing this level against the company’s current profitability and recent share price performance. See our latest analysis for Atos. That recent pullback to a €44.50 share price comes after a 30 day share price return of a 22.11% decline and a year to date share price return of a 14.65% decline, even though the 1 year total shareholder return sits at 64.81% while the 5 year...
ENXTPA:EL
ENXTPA:ELMedical Equipment

EssilorLuxottica (ENXTPA:EL) Margin Slippage Tests Bullish Earnings Expansion Narrative

EssilorLuxottica Société anonyme (ENXTPA:EL) has put fresh numbers on the table for FY 2025, with second half revenue of €14.5b, basic EPS of €2.01 and net income of €928m, while trailing twelve month revenue sits at €28.5b with EPS of €5.04 and net income of €2.3b. The company has seen revenue move from €13.2b and EPS of €2.18 in 2024 H2 to €14.5b and EPS of €2.01 in 2025 H2, alongside forecast annual revenue growth of 8.1% and EPS growth of 13.3%. Investors are likely to focus on how these...